|
Mar 5
|
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
|
|
Feb 26
|
12 $10 Stocks That Will Triple
|
|
Feb 26
|
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
|
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Dec 8
|
Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Dec 6
|
Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade
|
|
Nov 7
|
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
|
|
Nov 7
|
Entrada Therapeutics, Inc. (TRDA) Surpasses Q3 Earnings and Revenue Estimates
|
|
Nov 6
|
Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
|
|
Oct 5
|
Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things
|
|
Aug 8
|
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
|